Advertisement
Screener

LIFECORE BIOMEDICAL, INC. (LFCR) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share

1.9 / 5 stars · 43/114 Roast Me

LIFECORE BIOMEDICAL, INC. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share

LIFECORE BIOMEDICAL, INC. (LFCR) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 7-month period ending 2025-12-31, per its 10-KT filed 2026-03-16.

Financial Statements › Income Statement › Net Income

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2026-03-16

  • LIFECORE BIOMEDICAL, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2025-02-23 was $0.00, a 100.00% decline year-over-year.
  • LIFECORE BIOMEDICAL, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-11-24 was $0.00.
  • LIFECORE BIOMEDICAL, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-08-25 was $0.00, a 100.00% decline year-over-year.
  • LIFECORE BIOMEDICAL, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-02-25 was $0.03.
  • LIFECORE BIOMEDICAL, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • LIFECORE BIOMEDICAL, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2024 was $0.09.
  • LIFECORE BIOMEDICAL, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2023 was -$1.18.
  • LIFECORE BIOMEDICAL, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2022 was -$3.44.
Period endIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month as first filedIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month as first filedIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 7 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month as first filedIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month as first filed
2025-12-31$0.00
10-KT · filed 2026-03-16
2025-05-25$0.00
10-KT · filed 2026-03-16
2025-02-23$0.00
10-Q · filed 2025-04-03
$0.00
10-Q · filed 2025-04-03
2024-11-24$0.00
10-Q · filed 2025-01-02
$0.00
10-Q · filed 2025-01-02
2024-08-25$0.00
10-Q · filed 2024-10-04
2024-05-26$0.09
10-KT · filed 2026-03-16
2024-02-25$0.03
10-Q · filed 2025-04-03
$0.09
10-Q · filed 2025-04-03
2023-11-26$0.00
10-Q · filed 2025-01-02
$0.06
10-Q · filed 2025-01-02
2023-08-27$0.06
10-Q · filed 2024-10-04
2023-05-28-$0.09
10-K · filed 2024-03-20
-$1.18
10-K · filed 2024-08-26
2023-02-26-$0.83
10-Q · filed 2024-08-09
-$0.82
10-Q · filed 2023-06-02
-$1.11
10-Q · filed 2024-08-09
-$0.98
10-Q · filed 2023-06-02
2022-11-27-$0.12
10-Q · filed 2024-08-09
$0.00
10-Q · filed 2023-03-16
-$0.26
10-Q · filed 2024-08-09
$0.00
10-Q · filed 2023-03-16
2022-08-28-$0.14
10-Q · filed 2024-08-09
$0.00
10-Q · filed 2022-10-07
2022-05-29-$1.76
10-K · filed 2024-03-20
-$0.06
10-K · filed 2022-09-14
-$3.44
10-K · filed 2024-08-26
-$1.74
10-K · filed 2022-09-14
2022-02-27-$0.09
10-K · filed 2024-03-20
-$0.19
10-Q · filed 2022-04-07
-$1.68
10-Q · filed 2023-06-02
-$1.71
10-Q · filed 2022-04-07
2021-11-28-$1.56
10-K · filed 2024-03-20
-$1.44
10-K · filed 2022-09-14
-$1.51
10-Q · filed 2023-03-16
2021-08-29-$0.03
10-K · filed 2024-03-20
-$0.08
10-K · filed 2022-09-14
2021-05-30-$0.07
10-K/A · filed 2023-03-16
-$0.30
10-K · filed 2024-03-20
$0.00
10-K · filed 2021-07-29
2021-02-28-$0.18
10-K · filed 2024-03-20
-$0.14
10-Q · filed 2022-04-07
-$0.72
10-Q · filed 2022-04-07
2020-11-29-$0.11
10-K · filed 2024-03-20
-$0.37
10-K · filed 2022-09-14
2020-08-30-$0.08
10-K · filed 2024-03-20
-$0.21
10-K · filed 2022-09-14
2020-05-31-$0.56
10-K/A · filed 2023-03-16
$0.00
10-K · filed 2020-08-14
2020-02-23$0.00
10-Q · filed 2020-04-03
$0.00
10-Q · filed 2020-04-03
2019-11-24$0.00
10-Q · filed 2020-01-02
$0.00
10-Q · filed 2020-01-02
2019-08-25$0.00
10-Q · filed 2019-10-03
2019-05-26-$0.06
10-K · filed 2021-07-29
2019-02-24-$0.02
10-Q · filed 2020-04-03
$0.00
10-Q · filed 2019-04-04
-$0.04
10-Q · filed 2020-04-03
$0.00
10-Q · filed 2019-04-04
2018-11-25-$0.02
10-Q · filed 2020-01-02
-$0.02
10-Q · filed 2020-01-02
2018-08-26$0.00
10-Q · filed 2019-10-03
2018-05-27-$0.03
10-K · filed 2020-08-14
2018-02-25-$0.01
10-Q · filed 2019-04-04
-$0.01
10-Q · filed 2019-04-04
2017-08-27-$0.01
10-Q · filed 2018-10-05
2017-05-28$0.02
10-K · filed 2019-08-01
2016-05-29$0.02
10-K · filed 2018-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADC Therapeutics SA (ADCT)$0.163B-1.39
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Annexon, Inc. (ANNX)United States$0.147B-4.22
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Atrium Therapeutics, Inc. (RNA)United States$0.140B